GOLD will make us GOLD 🌟Hi there, Yurii Domaranskyi here.
Risk vs Reward = 1 to 27.92 ✨
It means if you risk here 100$ you may make 2792$ Not bad, huh?
Yuriidomaranskyi
Looks like the reversal may start from here! 🥰Hi there, Yurii Domaranskyi here.
Risk vs Reward = 1 to 44.48 ✨
It means if you risk here 100$ you may make 4448$ Not bad, huh?
No brainer, it's buying here, with such risk vs reward! 🏆Hi there, Yurii Domaranskyi here.
Risk vs Reward = 1 to 12.43 ✨
It means if you risk here 100$ you may make 1243$ Not bad, huh?
+ Dividends 11.02% per year, which is mesmerazing.
Advanced Flower Capital Gamma (AFC Gamma, NASDAQ AFCG) is a leading provider of institutional loans to high-quality cannabis companies nationwide in all aspects of production: cultivation, processing, and distribution. We offer loans and related facilities, generally secured by substantial assets such as real estate, licenses and cash flow. With years of combined lending expertise and real-estate experience, AFC Gamma’s principles are now focused on the exponential growth of the cannabis industry.
It's borring stock, I know. 🔥 🔥 🔥
1. The stock has a long base, it has traded sideways in a narrow vertical range for an extended period of time. This boring trading activity tends to weed out the emotionally-charged short-term traders. . The only shareholders left are the long-term fundamentally-biased shareholders who have no intention of selling their shares any time soon. The longer a stock sets up in a base, the larger the ultimate advance. Stocks that have been basing for a year or more generally offer no clue signaling a break out to the upside.
2 . The stock broke out above 30 week moving average. After It did it, the volume expanded.
3. The 30-week moving average starts to rise.
4. High angle of attack about 40 degrees
5. The stock is under 15$ As a matter of arithmetic, the stocks with the largest percentage moves begin their moves from lower prices. The great thing about a lower priced stock is that it becomes “marginable” around $4 or $5 (depending on the particular broker). To put it simply, when a stock meets this margin threshold, a broker will allow shareholders to borrow 100%-300% or more of the stock’s value to purchase additional shares.
6. Nice clean chart.
7. Had prior momentum.
8. Has consistently reported quarterly revenue and earnings per share that have not deviated significantly from each other over the past few quarters
9. The company recently required other company.
10. P/E 12.49
11. SEQUENTIAL IMPROVEMENT in revenue and earnings
12. INCREASING MARGINS
margin percentage increase from 11.5% during Fiscal 2020 to 12.4% during Fiscal 2021.
13. OPEN MARKET INSIDER BUYING
2022-03-24 14:09:01
2022-03-23
ELA Destefano Allison M Dir P - Purchase $4.40 +1,000 135,026 +1% +$4,400
2022-03-22 14:36:59
2022-03-21
ELA Destefano Allison M Dir P - Purchase $4.40 +2,671 134,026 +2% +$11,752
2022-03-22 09:35:41
2022-03-21
ELA Schepp Richard D Dir P - Purchase $4.39 +15,000 15,000 New +$65,850
2022-03-22 09:35:39
2022-03-21
ELA Pedersen Bret Allen CFO P - Purchase $4.28 +731 50,927 +1% +$3,129
2021-08-10 12:06:33
2021-08-09
ELA Pedersen Bret Allen CFO P - Purchase $4.71 +650 50,196 +1% +$3,062
2021-05-26 17:25:10
2021-05-26
ELA Destefano Allison M Dir P - Purchase $4.38 +2,300 131,355 +2% +$10,074
2021-05-11 09:30:45
2021-05-10
ELA Pedersen Bret Allen CFO P - Purchase $4.02 +2,053 97,999 +2% +$8,243
14. LOW FLOAT AND LOW MARKET CAP
Shs Outstand 26.93M
Shs Float 7.52M
15. Optionable? Yes. Much better if it's not.
16. Short Float 1.68%
17. A GREAT TICKER!
MAC had a huge accumulation! Hi everyone, Yurii Domaranskyi here. Let's take a look at the chart:
1. Price levels are working good here
2. Globally uptrend and locally range
3. The level confirmed by a few touches
4. Huge accumulation in the range
5. Great potential 1 to 13.5 risk/reward
6. The price came from above
7. Report was 5 days ago
8. In 2 days dividends
9. Macerich Q4 earnings rise as traffic returns, occupancy rises
10. Macerich FFO of $0.53 beats by $0.05, revenue of $229.4M beats by $23.72M
Potential risk/reward ratio = 1 to 13.5 meaning that potential risk 100$ with the possibility to make 13.5$
If it does make sense to you, press a thumb up! 👍
FOMO *fear of missing out* diactivated😂Here you go, a great trading opportunity based on level of rollback, waiting for the stock to make a false breakdown first
❤️Please, support our work with like & comment!❤️
Here is Friday's treat ^)Looks so attractive, don't you think?
❤️Please, support our work with like & comment!❤️
Enel Chile - ENIC stock. Where to buy? 🧙In this video you'll learn what is a good entry point for ENIC, where to put stop loss and what are the reasonable profit targets.
Bluebird Bio Inc 🧙bluebird bio Inc is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.
Here you can see pipeline:
Betibeglogene autotemcel (beti-cel) (LentiGlobin) - HGB-212 Northstar-3 Phase 3 updated at EHA June 11, 2021. 89% (32/36) of evaluable patients achieved transfusion independence (TI) and remain transfusion free (HGB-207, HGB-212)
Betibeglogene autotemcel (beti-cel) (LentiGlobin) - HGB-207 Northstar-2 Phase 3 updated at EHA June 11, 2021. 89% (32/36) of evaluable patients achieved transfusion independence (TI) and remain transfusion free (HGB-207, HGB-212)
Lenti-D (Elivaldogene Autotemcel / Eli-Cel) - ALD-102 Phase 2/3 updated data presented March 15, 2021. 90% of evaluable patients (27/30) alive and free of major functional disabilities at two years follow-up.
Betibeglogene autotemcel (beti-cel) (LentiGlobin) BLA filing to be completed
Betibeglogene autotemcel (beti-cel) (LentiGlobin) - HGB-206 Phase 1/2 trial temporarily suspended due to a reported Suspected Unexpected Serious Adverse Reaction (SUSAR) of acute myeloid leukemia (AML) - February 16, 2021. Clinical hold lifted June 7, 2021. Data to be presented by end of 2021.
Lenti-D (Elivaldogene Autotemcel / Eli-Cel) - ALD-104 Phase 3 safety data to be presented at EBMT 2020. Noted two adverse events (out of 13 patients) of pancytopenia were considered possibly related to Lenti-D. Phase 3 trial placed on clinical hold - noted August 9, 2021. BLA filing due 2021 subject to resolution of the clinical hold.
ABECMA (idecabtagene vicleucel) Phase 1 data presented at ASH 2020.
bb21217 (CRB-402) Phase 1 data due by end of 2021.
MGTA-145 and plerixafor Phase 2 trial to be initiated 4Q 2021.
Betibeglogene autotemcel (beti-cel) (LentiGlobin) - (HGB-210) Phase 3 trial temporarily suspended due to a reported Suspected Unexpected Serious Adverse Reaction (SUSAR) of acute myeloid leukemia (AML) - February 16, 2021. Clinical hold lifted June 7, 2021.
OUTSTANDING STOCK VS FLOATING STOCK 🧶Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s officers and insiders.
Floating stock, aka float, refers to the number of shares a company actually has available to trade in the open market.
Jianpu Technology Inc ADR 🧙Jianpu Technology Inc is an independent open platform for providing online discovery and recommendation services for financial products in China. The company provides users with personalized search results and recommendations services such as loan applications, credit card services, and advertising and marketing services to its financial needs and credit profile. The individual users have access to financial products through the platform, including credit cards, and wealth management products. In addition, it also offers data risk management solutions to financial service providers which help in application approval, fraud detection and prevention and other credit underwriting processes. The company generates revenues from fees charged for services for loan products.
Industry
Custom Computer Programming Services
If you want not to miss ideas like this one,🎯 subscribe and press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
BRQS Education Group 🧙 SHOCKING RISK-REWARD OPPORTUNITY!!!Borqs Technologies Inc operates as a software development company. It is engaged in software, development services, and products providing customizable, differentiated, and scalable Android-based smart connected devices and cloud service solutions. The company's segments include Yuantel and Connected Solution. Borqs derives most of its revenues from its Connected Solution which includes Software and Hardware. Its geographical segments include China, India, the United States, and the Rest of the World, of which the majority of the revenue comes from India.
Industry
Software - Application
If you want not to miss ideas like this one,🎯 subscribe and press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
API Education Group 🧙Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.
Industry
Software - Application
If you want not to miss ideas like this one,🎯 subscribe and press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
DouYu International Holdings Ltd ADR 🧙DouYu International Holdings Ltd is a game-centric live streaming platform in China. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.
Industry
Internet Content & Information
If you want not to miss ideas like this one,🎯 subscribe and press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
Viomi Technology Co Ltd 🧙Viomi Technology Co Ltd along with its subsidiaries provides Internet of Things (IoT) enabled smart home products through its platform. Products offered by the company include 21Face smart refrigerator, Viomi dishwasher, Eyebot smart range hood, VioV smart speaker, smart mirror, smart water purification systems, smart kitchen products and other smart products. It generates revenues mainly from the sales of its IoT products, consumable products, and from our value-added businesses.
First Quarter 2021 Financial and Operating Highlights
Net revenues reached RMB1,255.6 million (US$191.6 million), an increase of 64.0% from the first quarter of 2020.
Gross margin was 21.1%, compared to 18.8% for the first quarter of 2020.
Net income attributable to ordinary shareholders of the Company increased by 173.2% to RMB49.1 million (US$7.5 million) from RMB18.0 million for the first quarter of 2020.
Non-GAAP net income attributable to ordinary shareholders of the Company1 increased by 106.8% to RMB65.3 million (US$10.0 million) from RMB31.6 million for the first quarter of 2020.
Number of cumulative household users reached to approximately 5.6 million, compared to approximately 5.1 million as of the end of 2020 and approximately 3.7 million as of the end of the first quarter of 2020.
Percentage of household users with at least two connected products reached 20.4%, compared to 20.0% as of the end of 2020 and 18.4% as of the end of the first quarter of 2020.
If you want not to miss ideas like this one,🎯 subscribe and press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
Cardiff Oncology Inc 🧙Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias.
If you want not to miss ideas like this one,🎯 subscribe and press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
HOOKIPA Pharma Inc 🧙HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.
If you want not to miss ideas like this one,🎯 subscribe and press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
Canaan Inc 🧙Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment as well as the supplier of the overall scheme for computer software and hardware of digital blockchain. The equipment manufactured by Canaan is sold to many countries including China, the United States, Hong Kong, and other foreign countries. It derives a vast majority of the revenue from China. Its product includes Kanzhi Al and Avalon Mining Machine.
If you want not to miss ideas like this one,🎯 subscribe and press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
BTRS Holdings Inc 🧙BTRS Holdings Inc is a provider of cloud-based software and integrated payment processing solutions. The company is at the forefront of the digital transformation of AR, providing mission-critical solutions that span credit decisions and monitoring, online ordering, invoice delivery, payments and remittance capture, cash application and collections.
If you want not to miss ideas like this one,🎯 subscribe and press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
Bit Digital Inc 🧙Bit Digital Inc is engaged in the bitcoin mining business. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. It generates revenue from cryptocurrency mining.
Setup A Technically
Setup A+ Fundamentally
I was about to buy BTC on 5% of my capital, and after some thinking I decided to buy a company wich produces BTC
United States, Canada, Hong Kong
Short Volume Ratio 17%
ATR 0.57
RVOL 0.77
Float37.11M
Insider Ownership23.20%
Institutional Ownership1.60%
Market Cap334.6867 Mil
52 Week High 33
Average 10 Day Volume2,788,611
Average 30 Day Volume2,887,668
No Dividends
Price/Book4.46
Debt/Equity N/A
28% Discount
last report was great
some institutions were buying in MAY
If you want not to miss ideas like this one,🎯 subscribe and press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
Teva Pharmaceutical Industries Ltd 🧙Headquartered in Israel, Teva Pharmaceutical is the largest generic drug manufacturer in the world. The company was formed in 1901 and has a portfolio of more than 3,500 medicines--roughly 1 out of 9 generic prescriptions in the U.S. is filled with a Teva product. The company also develops branded pharmaceuticals in the central nervous system, oncology, and respiratory categories. Teva's generic drug sales represent slightly over half of total revenue, with branded drug and distribution revenue making up the balance. Teva is an aggressive filer to bring generic drugs to market when brand patents expire and has the most generic products pending Food and Drug Administration approval.
If you want not to miss ideas like this one,🎯 subscribe and press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
Black Diamond Therapeutics Inc 🧙Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under pipeline are BDTX-189 and BDTX-1535.
If you want not to miss ideas like this one,🎯 subscribe and press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
Achieve Life Sciences Inc 🧙Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the global smoking health epidemic through the development and commercialization of cytisinicline.
If you want not to miss ideas like this one,🎯 subscribe and press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
